Lesley Solomon, M.B.A.

Ruslan's vision around food allergy and the FASI team's support of it will change the world. The way the scientists are thinking about food allergies now versus the way they were looking at them five years ago is more mechanistic and systemic in a way that can only create real impact for patients. I am thrilled to be part of this effort in support of my food allergic son and millions of others across the globe.

Lesley Solomon is a Venture Chair at Redesign Health, a mission-driven idea-to-launch platform that creates, builds and scales transformative healthcare companies. We conduct deep fundamental research and leverage an extensive network of industry experts, corporate partners, and investors to support extraordinary entrepreneurs. Our companies work tirelessly to transform the healthcare system — elevating patient experience, increasing transparency, and democratizing access to high-quality care.

In 2017, Lesley became Dana-Farber’s first SVP and Chief Innovation Officer. She previously served as the founding executive director of Brigham and Women’s Innovation Hub and as director of strategy and innovation in the Brigham Research Institute. At Dana-Farber Lesley led a team focused on commercializing DFCI’s science and technology, working with industry, academic, and investment partners to accelerate the pace of getting that work to patients. She developed several innovative models for partnerships to sustain the Institute’s research funding and created new ways to expand the reach of DFCI’s clinical care. At Brigham, Lesley and her team focused on two core areas; supporting Brigham faculty with ideveloping solutions to their ideas for care improvement and working with hospital administration to partner with healthcare startups to solve challenges across the system.

Lesley has more than 25 years of experience as an executive working in business development, strategy, and marketing at startups, early-stage, and large companies such as the Food Network, Barnes & Noble.com, and Yoga Works. She received her MBA from Harvard Business School and has a BA in English from Cornell University. Lesley is a founding advisor to AllerFund and a board member at Verastem Oncology. Lesley received the 2020 Extraordinary Women Advancing Healthcare Award by The Commonwealth Institute and was named a 2020 Woman to Watch in IT by Becker’s Hospital Review. She is also the mother of a son with food allergies.